TPN2.0 research named Clinical Research Forum Top 10 Finalist

The Nature Medicine study behind TPN2.0 was selected as a finalist for the 2026 Top 10 Clinical Research Achievement Awards by the Clinical Research Forum. The awards are among the most competitive recognitions in U.S. clinical research, with nominations drawn from nearly 60 research institutions and hospitals.

The recognition places TPN2.0 research alongside studies in gene therapy, oncology, and cardiovascular medicine that typically dominate the list. The awards will be presented in May 2026 in Washington, D.C.